Triglav Skladi’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Hold
18,060
– – 0.08% 124
2026
Q2
$1.63M Hold
18,060
– – 0.09% 116
2026
Q1
$1.45M Hold
18,060
– – 0.1% 107
2025
Q4
$1.54M Sell
18,060
-2,000
-10% -$164K 0.1% 106
2025
Q3
$1.56M Hold
20,060
– – 0.1% 91
2025
Q2
$1.57M Hold
20,060
– – 0.11% 90
2025
Q1
$1.45M Hold
20,060
– – 0.12% 88
2024
Q4
$1.49M Hold
20,060
– – 0.12% 88

Other funds holding EW

Triglav Skladi's EW Position: Q3 2026 in Review

Triglav Skladi held its Edwards Lifesciences (EW) position steady in Q3 2026 at 18,060 shares worth $1.56M. The position accounts for 0.08% of the portfolio, ranked #124.

Triglav Skladi first reported a position in EW in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.63M in Q2 2026. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Triglav Skladi held 18,060 shares of Edwards Lifesciences worth $1.56M as of Q3 2026.
  • Triglav Skladi left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up 0.08% of Triglav Skladi's portfolio in Q3 2026, its #124 holding.
  • Triglav Skladi first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 8 quarters since.
  • Triglav Skladi's Edwards Lifesciences position peaked at $1.63M in Q2 2026.
  • 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Triglav Skladi's 13F filing for Q3 2026, filed 6 Nov 2026.